Data on M&A Activity in the Pharmaceutical Market

This database contains a list of M&A deals involving branded drugs available in the US market that were on-patent at the time of the deal — company acquisitions, asset acquisitions (drugs or subsidiaries), and licensing deals. The information comes from publicly available press releases and other documents; links to all source documents are included in a companion file. See the README for variable definitions and coding notes. The database was assembled for “Mergers that Matter: The Impact of M&A Activity in Prescription Drug Markets”. If you use the data, please also cite the paper.